Biotech

All Articles

Biogen, UCB document stage 3 lupus succeed after falling short earlier trial

.Biogen and UCB's bank on improving in to phase 3 astride an unsuccessful research study wants to ha...

Aptadir hopes new RNA preventions can easily reverse tricky cancers cells

.Italian biotech Aptadir Rehabs has actually released with the promise that its pipe of preclinical ...

Wave surfs DMD effectiveness to regulatory authorities' doors, sending stockpile

.Wave Lifestyle Sciences has fulfilled its own objective in a Duchenne muscle dystrophy (DMD) resear...

Sanofi tweezes brand-new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma crease, occupying the...

Achilles drips cell therapy system, braces for unemployments after missing 'commercial viability' objectives

.Achilles Therapies has actually wrecked its own approach. The English biotech is stopping work on i...

Aligos trumpets period 2 MASH gain, lowering liver body fat around 46%

.Aligos Rehabs is heralding a midstage gain in metabolic-dysfunction associated steatohepatitis (MAS...

Basilea scores $268M BARDA funding for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work building brand-new antifungals has acquired a significant increase com...

Capricor markets Europe liberties to late-stage DMD therapy for $35M

.Having presently scooped up the USA legal rights to Capricor Therapies' late-stage Duchenne muscle ...

FDA junks adcomm for Applied's uncommon illness medicine

.After pushing back the selection meeting for Applied Rehabs' metabolic disorder drug govorestat, th...

Novo inks $600M NanoVation package to analyze genetic drugs ex-liver

.Novo Nordisk is continuing its press into genetic medicines, accepting compensate NanoVation Therap...